Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Foot-and-mouth disease virus serotype O (FMDV-O) is a highly contagious viral pathogen within the Aphthovirus genus of the Picornaviridae family, primarily affecting cloven-hoofed animals such as cattle, pigs, and sheep [11, 14]. It is the most prevalent of the seven FMDV serotypes, responsible for the majority of global outbreaks [16, 18]. The virus features a positive-sense single-stranded RNA genome that encodes a polyprotein subsequently cleaved by viral proteases, most notably the 3C protease (3Cpro), into functional structural and non-structural proteins [1, 3]. Therapeutic interventions include the use of inactivated vaccines, which provide serotype-specific protection, and the development of small-molecule inhibitors targeting essential viral enzymes like 3Cpro and the 3D RNA-dependent RNA polymerase (3Dpol) [2, 4, 13]. Neutralizing antibodies often target the VP1 capsid protein, specifically the G-H loop containing the RGD motif that mediates binding to host cell integrin receptors [6, 14]. Management of FMDV-O is complicated by its high mutation rate, leading to antigenic drift and a lack of cross-protection between different serotypes [10, 20].
Inhibition of viral 3C protease, inhibition of 3D RNA-dependent RNA polymerase, neutralization of viral particles, and induction of host antiviral state.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Foot-and-mouth disease virus serotype O (FMDV-O).